INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

11151	Companies
246076	Keywords
174054	Articles
132822	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 8 months ago

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
Inventiva publie son bilan semestriel du contrat de liquidité avec Kepler Cheuvreux. Espèces de 349 630,55 € et 113 452 actions Inventiva au 31/12/2024. Analyse des transactions du semestre. Entreprise biopharmaceutique axée sur la stéatohépatite et autres maladies

Contrat De Liquidité Bilan Semestriel Kepler Cheuvreux Biopharmaceutique Inventiva
PRESS RELEASE

published on 01/24/2025 at 22:00, 1 year 8 months ago

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
Inventiva announces half-year liquidity contract review with Kepler Cheuvreux. Cash and shares available in the liquidity account disclosed. Company focuses on developing oral small molecule therapies for MASH and unmet medical needs

Liquidity Contract Kepler Cheuvreux Clinical-Stage Biopharmaceutical Inventiva MASH
BRIEF

published on 01/22/2025 at 22:05, 1 year 8 months ago

Inventiva's LEGEND Trial Results to be Presented at EASL SLD Summit 2025

Lanifibranor Empagliflozin LEGEND Trial MASH Treatment EASL Summit 2025
BRIEF

published on 01/22/2025 at 22:05, 1 year 8 months ago

Les résultats de l'essai LEGEND d'Inventiva seront présentés au sommet EASL SLD 2025

Lanifibranor Empagliflozine Essai De LEGEND Traitement MASH Sommet EASL 2025
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 8 months ago

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D

Inventiva MASH Lanifibranor Empagliflozin LEGEND Trial
PRESS RELEASE

published on 01/22/2025 at 22:00, 1 year 8 months ago

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025
Les résultats de LEGEND sur la combinaison de lanifibranor avec empagliflozine pour la MASH seront présentés au EASL SLD Summit 2025. Améliorations métaboliques et sécurité démontrées

MASH Lanifibranor Empagliflozine LEGEND EASL SLD Summit
BRIEF

published on 12/17/2024 at 22:05, 1 year 9 months ago

Inventiva présente à la J.P. Morgan Healthcare Conference

Investisseurs Inventiva NASH Lanifibranor J.P. Morgan Healthcare
BRIEF

published on 12/17/2024 at 22:05, 1 year 9 months ago

Inventiva to present at the JP Morgan Healthcare Conference

Investors Inventiva NASH Lanifibranor JP Morgan Healthcare
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 9 months ago

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »
Inventiva annonce sa participation à la 43rd Annual J.P. Morgan Healthcare Conference. Frédéric Cren présentera les activités de la Société le 15 janvier 2025 à San Francisco

Biopharmaceutique Inventiva MASH/NASH J.P. Morgan Healthcare Conference Frédéric Cren
PRESS RELEASE

published on 12/17/2024 at 22:00, 1 year 9 months ago

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference with CEO Frédéric Cren providing a corporate overview and engaging in investor meetings

Biopharmaceutical Inventiva J.P. Morgan Healthcare Conference Frédéric Cren Metabolic Dysfunction

Accesswire

Published on 10/09/2026 at 14:00, 2 hours 27 minutes ago

Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 2 hours 27 minutes ago

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 3 hours 4 minutes ago

SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 3 hours 27 minutes ago

Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 3 hours 27 minutes ago

Nepra Foods Launches Flagship PROPASTA Brand on Amazon

View all ACCESSWIRE

EQS Group

Published on 10/09/2026 at 15:55, 32 minutes ago

Bio-Gate AG reports first half results for 2026
Published on 10/09/2026 at 15:53, 33 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/09/2026 at 15:53, 34 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/09/2026 at 15:52, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 10/09/2026 at 15:51, 35 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc

Les Echos

Published on 10/08/2026 at 18:30, 21 hours 57 minutes ago

Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:30, 21 hours 57 minutes ago

Cegedim : Publication du Rapport Financier Semestriel 2026
Published on 10/08/2026 at 18:00, 22 hours 27 minutes ago

SMTPC - Communiqué sur le Chiffre d'affaires du 3ème trimestre 2026
Published on 10/08/2026 at 18:00, 22 hours 27 minutes ago

Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 18:00, 22 hours 27 minutes ago

Lancement de LINK, la nouvelle génération de THIN : Le premier Entrepôt de Données de Santé européen de Clinityx, validé par la CNIL pour 10 ans

View all LES ECHOS COMFI WIRE